Events & News

 

La NLM è lieta di annunciare che sono state donate 10.000 mascherine protettive alla Protezione Civile

News & Events

AC083 CeLia-Type Strip Assay CeLia–Type strip assay kit provides reagents for the identifi...

Dear All,

we are pleased to inform you of our participation at MEDLAB by Stand Z1-C40.

8 - 11 FEBRUARY 2021

Dubai International Convention and Exhibition Centre

Visit us at our stand 

 

 

This new test allows the identification of the principal variants of the CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) gene through the Fluorescent ARMS (Amplification Refractory Mutation Detection System) from DNA extracted from whole blood and blood spot and the subsequent fragment analysis with an automated genetic analyzer.

 

 

Nuclear Laser Medicine participated in EQAS 2016 (External Quality Assurance Services) organized by the German association INSTAND e V. (Düsseldorf) for the analysis of  Hepatitis C virus geno-/subtyping with the test NLM Gen-C 2.0 AC004/24.

Genetic polymorphisms associated to coronary artery disease

Genetic test for 13,18,21, X and Y chromosome aneuploidies

Molecular test for the quantification of Hepatitis B (HBV-DNA) and Hepatitits C (HCV-RNA) in human p...

 

Nuclear Laser Medicine srl
Viale delle Industrie, 3 - 20049
Settala (MI) - ITALIA
Tel: +39 02 952451 - Fax: +39 02 95245238/37

P.Iva/Cod.Fisc.: 08763060152 - Cap. Soc. € 110.000,00 i.v.

 

CERTIFIED QUALITY

Nuclear Laser Medicine srl is certified